ICER Founder Steve Pearson Analyzes COVID-19 Remdesivir Pricing on HealthBiz Podcast
Cost-effectiveness model embraced by US health plans and international health technology assessment agencies shows remdesivir value depends on mortality impact BOSTON, MASSACHUSETTS, UNITED STATES, November 12, 2020 /EINPresswire.com/ -- In the latest …